Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microarray-based classification and clinical predictors: on combined classifiers and additional predictive value.

Anne-Laure Boulesteix1, Christine Porzelius, Martin Daumer

  • 1Sylvia Lawry Centre for MS Research, Hohenlindenerstr. 1, D-81677 Munich, Germany. boulesteix@slcmsr.org

Bioinformatics (Oxford, England)
|June 12, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world walking speed as a digital biomarker and outcome measure for clinical trials-a systematic review, regulatory status and future directions.

Frontiers in digital health·2026
Same author

STrategies for developing REseArch Methods guidance (STREAM): Protocol.

Journal of clinical epidemiology·2026
Same author

The statistical software revolution in pharmaceutical development: challenges and opportunities in open source.

Drug discovery today·2026
Same author

On "Confirmatory" Methodological Research in Statistics and Related Fields.

Statistics in medicine·2025
Same author

ChatGPT as a Tool for Biostatisticians: A Tutorial on Applications, Opportunities, and Limitations.

Statistics in medicine·2025
Same author

Rethinking the Handling of Method Failure in Comparison Studies.

Statistics in medicine·2025
Same journal

conMItion: an R package adjusting confounding factors for associations in multi-omics.

Bioinformatics (Oxford, England)·2026
Same journal

SpaMFG: a Spatial Multi-omics Integration Method based on Feature Grouping.

Bioinformatics (Oxford, England)·2026
Same journal

CSCN: Inference of Cell-Specific Causal Networks Using Single-Cell RNA-Seq Data.

Bioinformatics (Oxford, England)·2026
Same journal

Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and Mediators.

Bioinformatics (Oxford, England)·2026
Same journal

Enhancing Cross-Context Generalization in Drug Perturbation Prediction with a Multimodal Conditional Diffusion Framework.

Bioinformatics (Oxford, England)·2026
Same journal

Primer Design through Submodular Function Estimation.

Bioinformatics (Oxford, England)·2026
See all related articles

This study introduces a novel bioinformatics method to evaluate the predictive value of microarray data alongside clinical parameters. The approach efficiently combines data types for improved cancer subtype classification and prediction accuracy.

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Clinical bioinformatics requires methods to assess the added predictive value of microarray data over clinical parameters alone.
  • Existing methods may not fully integrate diverse data types or identify novel subtypes.
  • A fair framework is needed to evaluate the additional predictive power of high-throughput data.

Purpose of the Study:

  • To develop a method for assessing the additional predictive value of microarray data in clinical settings.
  • To create an optimal prediction rule integrating both clinical and microarray data.
  • To identify cancer subtypes not discernible by clinical parameters alone.

Main Methods:

  • A two-step approach combining random forests and partial least squares (PLS) dimension reduction.

Related Experiment Videos

  • Incorporation of pre-validation through internal cross-validation to prevent overfitting.
  • Development of the freely available R package 'MAclinical'.

    • Main Results:

    • The proposed method is fast, flexible, and effective for assessing the significance of microarray data.
    • Demonstrated efficiency in simulations and applications to breast and colorectal cancer data.
    • Successfully built optimal hybrid classification rules integrating clinical and microarray data.

    Conclusions:

    • The novel two-step method provides a robust framework for integrating clinical and microarray data.
    • The approach enhances predictive accuracy and aids in identifying novel cancer subtypes.
    • The 'MAclinical' R package offers a practical tool for clinical bioinformatics research.